RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
0.00 (0.00%)0.49USD5.8K成交股數6.4M市值–本益比(近四季)17.2股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.4M | 1.4M | 2.1M | 3.7M | 4.1M | 4.7M | 6.9M | 5.6M | 5.8M | 9.6M | 8.3M | 5.5M |
| 銷售管理費用 | 1.2M | 1.8M | 1.9M | 2.3M | 2.4M | 1.6M | 1.6M | 2.5M | 2.1M | 2.0M | 3.1M | 1.5M |
| 營業利益 | −2.6M-60% | −3.3M-48% | −4.0M-52% | −6.1M-25% | −6.5M-17% | −6.3M-46% | −8.5M-25% | −8.1M+16% | −7.9M | −11.6M | −11.3M | −7.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.4M-62% | −3.2M-49% | −4.0M-52% | −6.1M-23% | −6.4M-13% | −6.3M-45% | −8.4M-29% | −7.9M+15% | −7.4M | −11.3M | −11.7M | −6.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.9M | 22.2M | 13.2M | 10.4M | 5.3M | 13.5M | 5.6M | 6.2M | 12.0M | 5.0M | 11.2M | 11.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 21.1M | 23.6M | 14.3M | 11.6M | 7.1M | 15.5M | 7.6M | 8.1M | 13.5M | 5.4M | 11.8M | 12.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.9M | 6.1M | 9.8M | 12.1M | 11.5M | 14.7M | 17.6M | 14.1M | 14.8M | 18.2M | 13.7M | 11.3M |
| 股東權益 | 15.2M | 17.4M | 4.5M | −459K | −4.5M | 813K | −10.0M | −6.0M | −1.3M | −12.8M | −1.8M | 1.6M |
| 負債比 | 28.1% | 26.0% | 68.3% | 103.9% | 163.0% | 94.8% | 230.8% | 175.0% | 110.0% | 337.8% | 115.3% | 87.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.8M | – | – | −8.2M-30% | – | – | – | −11.7M | – | – | −8.0M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −19.9M | –% | – | – |
| FY2024 | – | – | −29.9M | –% | – | – |
| FY2023 | – | – | −39.3M | –% | – | – |
| FY2022 | – | – | −28.3M | –% | – | – |
| FY2021 | – | – | −8.5M | –% | – | – |
| FY2021 | – | – | −8.5M | –% | -0.58 | – |
| FY2020 | – | – | −3.8M | –% | -1.24 | – |
| FY2020 | 1.3M | – | 618K | 46.7% | -0.21 | – |